SCM

Soleus Capital Management Portfolio holdings

AUM $1.45B
This Quarter Return
+34.67%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$555M
AUM Growth
+$555M
Cap. Flow
+$107M
Cap. Flow %
19.36%
Top 10 Hldgs %
64.54%
Holding
91
New
25
Increased
22
Reduced
13
Closed
17

Top Buys

1
THER
THERATECHNOLOGIES INC COM
THER
$26.9M
2
KRYS icon
Krystal Biotech
KRYS
$12.1M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$11M
4
AZN icon
AstraZeneca
AZN
$9.65M
5
CCCC icon
C4 Therapeutics
CCCC
$7.23M

Top Sells

1
NVTA
Invitae Corporation
NVTA
$10.2M
2
EPIX icon
ESSA Pharma
EPIX
$8.88M
3
VCEL icon
Vericel Corp
VCEL
$7.31M
4
MRSN icon
Mersana Therapeutics
MRSN
$5.5M
5
EXEL icon
Exelixis
EXEL
$4.71M

Sector Composition

1 Healthcare 90.73%
2 Consumer Staples 1.79%
3 Real Estate 0.62%
4 Financials 0.57%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
STAA icon
51
STAAR Surgical
STAA
$1.36B
$1.76M 0.32% 16,700 +13,400 +406% +$1.41M
CMPS
52
Compass Pathways
CMPS
$424M
$1.57M 0.28% 42,743 – –
IMDX
53
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
$1.54M 0.28% +297,000 New +$1.54M
OSH
54
DELISTED
Oak Street Health, Inc.
OSH
$1.5M 0.27% 27,612 – –
CMAX
55
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$1.44M 0.26% +118,900 New +$1.44M
MORF
56
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.36M 0.25% +21,500 New +$1.36M
SRRK icon
57
Scholar Rock
SRRK
$3.14B
$1.32M 0.24% 26,101 +1,617 +7% +$81.9K
KDMN
58
DELISTED
Kadmon Holdings, Inc.
KDMN
$1.31M 0.24% 336,442 – –
PVLA
59
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$1.29M 0.23% 500,000 – –
DNTH icon
60
Dianthus Therapeutics
DNTH
$759M
$1.18M 0.21% +100,000 New +$1.18M
VRDN icon
61
Viridian Therapeutics
VRDN
$1.5B
$1.13M 0.2% 67,685 -13,500 -17% -$226K
TRIL
62
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.12M 0.2% 103,819 – –
KYMR icon
63
Kymera Therapeutics
KYMR
$2.95B
$1.09M 0.2% 28,116 +15,000 +114% +$583K
ADVM icon
64
Adverum Biotechnologies
ADVM
$64.6M
$986K 0.18% 99,992 -36,000 -26% -$355K
ONCR
65
DELISTED
Oncorus, Inc.
ONCR
$929K 0.17% 66,722 +10,300 +18% +$143K
RVNC
66
DELISTED
Revance Therapeutics, Inc.
RVNC
$870K 0.16% 31,136 – –
MRTX
67
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$594K 0.11% 3,466 -4,372 -56% -$749K
TPTX
68
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$528K 0.1% 5,577 -13,436 -71% -$1.27M
HIMS.WS
69
DELISTED
Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an
HIMS.WS
$404K 0.07% +91,793 New +$404K
CRDF icon
70
Cardiff Oncology
CRDF
$140M
$395K 0.07% 42,684 -14,225 -25% -$132K
ABBV icon
71
AbbVie
ABBV
$372B
– – -21,477 Closed -$2.3M
AXGN icon
72
Axogen
AXGN
$743M
– – -33,813 Closed -$605K
BIIB icon
73
Biogen
BIIB
$19.4B
– – -3,899 Closed -$955K
CRSP icon
74
CRISPR Therapeutics
CRSP
$4.71B
– – -10,825 Closed -$1.66M
FATE icon
75
Fate Therapeutics
FATE
$120M
– – -6,830 Closed -$621K
1 2
3
4